Stifel Financial
EBS icon

Stifel Financial’s Emergent Biosolutions EBS Stock Holding History

Stifel Financial’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$170K Buy
20,235
+85
+0.4% +$711 ﹤0.01% 3547
2026
Q1 		$167K Buy
20,150
+566
+3% +$5.86K ﹤0.01% 3477
2025
Q4 		$242K Sell
19,584
-610
-3% -$6.54K ﹤0.01% 3282
2025
Q3 		$178K Buy
+20,194
New +$157K ﹤0.01% 3372
2024
Q4 		– Sell
-11,460
Closed -$95.7K – 3409
2024
Q3 		$95.7K Buy
+11,460
New +$104K ﹤0.01% 3245
2022
Q1 		– Sell
-10,538
Closed -$458K – 3396
2021
Q4 		$458K Buy
10,538
+301
+3% +$13.6K ﹤0.01% 2636
2021
Q3 		$512K Buy
10,237
+6,127
+149% +$371K ﹤0.01% 2561
2021
Q2 		$258K Sell
4,110
-2,124
-34% -$136K ﹤0.01% 2994
2021
Q1 		$578K Buy
6,234
+888
+17% +$90.9K ﹤0.01% 2386
2020
Q4 		$479K Sell
5,346
-4,170
-44% -$383K ﹤0.01% 2343
2020
Q3 		$984K Sell
9,516
-5,230
-35% -$564K ﹤0.01% 1645
2020
Q2 		$1.17M Sell
14,746
-2,575
-15% -$192K ﹤0.01% 1451
2020
Q1 		$1M Buy
17,321
+4,378
+34% +$252K ﹤0.01% 1432
2019
Q4 		$696K Sell
12,943
-2,699
-17% -$146K ﹤0.01% 2059
2019
Q3 		$817K Buy
15,642
+1,404
+10% +$65.4K ﹤0.01% 1877
2019
Q2 		$690K Sell
14,238
-2,595
-15% -$124K ﹤0.01% 2025
2019
Q1 		$853K Sell
16,833
-2,350
-12% -$139K ﹤0.01% 1752
2018
Q4 		$1.14M Buy
19,183
+3,332
+21% +$215K ﹤0.01% 1451
2018
Q3 		$1.04M Sell
15,851
-668
-4% -$39K ﹤0.01% 1643
2018
Q2 		$831K Sell
16,519
-2,395
-13% -$125K ﹤0.01% 1747
2018
Q1 		$995K Buy
18,914
+4,105
+28% +$205K ﹤0.01% 1566
2017
Q4 		$689K Buy
14,809
+1,237
+9% +$52.1K ﹤0.01% 1738
2017
Q3 		$548K Hold
13,572
– – ﹤0.01% 1828
2017
Q2 		$461K Buy
13,572
+513
+4% +$15.8K ﹤0.01% 1909
2017
Q1 		$379K Buy
13,059
+4,401
+51% +$134K ﹤0.01% 1970
2016
Q4 		$284K Buy
+8,658
New +$260K ﹤0.01% 2068
2016
Q1 		– Sell
-6,189
Closed -$248K – 2272
2015
Q4 		$248K Buy
+6,189
New +$216K ﹤0.01% 2013

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Stifel Financial's EBS Position: Q2 2026 in Review

Stifel Financial increased its Emergent Biosolutions (EBS) stake by 0.42% in Q2 2026, buying an estimated $711 and bringing the position to 20,235 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #3547.

Stifel Financial first reported a position in EBS in Q4 2015 and has held it in 27 quarters since. The position peaked at $1.17M in Q2 2020. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Stifel Financial held 20,235 shares of Emergent Biosolutions worth $170K as of Q2 2026.
  • Stifel Financial bought 85 Emergent Biosolutions shares in Q2 2026, an estimated $711.
  • Emergent Biosolutions made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #3547 holding.
  • Stifel Financial first reported a position in Emergent Biosolutions in Q4 2015 and has held it in 27 quarters since.
  • Stifel Financial's Emergent Biosolutions position peaked at $1.17M in Q2 2020.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.